Period:
Draw Mode:
| Volume | 801 |
|
|||||
| News | - | ||||||
| Day High | 1.85 | Low High |
|||||
| Day Low | 1.70 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Regen Biopharma Inc (PK) | RGBP | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.155 | 9.39% | 1.805 | 16:10:02 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.70 | 1.70 | 1.85 | 1.805 | 1.65 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 15 | 801 | $ 1.7933 | $ 1,436 | - | 1.03 - 10.95 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:33:35 | 4 | $ 1.85 | USD |
Regen Biopharma Inc (PK) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 259.11M | 3.38M | - | 77k | -1.73M | -0.01 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Regen Biopharma (PK) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RGBP Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.84 | 1.98 | 1.60 | 1.73 | 3,251 | -0.035 | -1.9% |
| 1 Month | 1.44 | 2.02 | 1.40 | 1.82 | 7,275 | 0.365 | 25.35% |
| 3 Months | 1.785 | 2.02 | 1.03 | 1.76 | 7,093 | 0.02 | 1.12% |
| 6 Months | 2.04 | 2.615 | 1.03 | 1.84 | 6,673 | -0.235 | -11.52% |
| 1 Year | 9.75 | 10.95 | 1.03 | 5.80 | 8,384,839 | -7.95 | -81.49% |
| 3 Years | 0.60 | 122.85 | 0.30 | 28.58 | 69,306,784 | 1.21 | 200.83% |
| 5 Years | 15.90 | 122.85 | 0.0015 | 24.81 | 48,051,242 | -14.10 | -88.65% |
Regen Biopharma (PK) Description
| Regen BioPharma Inc. is a publicly traded biotechnology company (OTCQB: RGBP) and (OTCQB: RGBPP). The Company is focused on the immunology and immunotherapy space. The Company is focused on rapidly advancing novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is focused on small molecule therapies for treating cancer and autoimmune disorders. Additional information on Regen BioPharma is available at http://www.regenbiopharmainc.com. |